Roth Capital Starts Actinium Pharma (ATNM) at Buy, PT $5
Tweet
Share
E-mailGet Alerts ATNM Hot Sheet
Price: $1.00 --0%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Join SI Premium – FREE
Roth Capital initiated coverage on Actinium Pharma (NYSE: ATNM) with a Buy rating and a price target of $5.00.
For an analyst ratings summary and ratings history on Actinium Pharma click here. For more ratings news on Actinium Pharma click here.
Shares of Actinium Pharma closed at $1.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Assumes Broadcom Limited (AVGO) at Buy
- H.C. Wainwright Starts NeuroSense Therapeutics Ltd. (NRSN) at Buy
- Morgan Stanley Resumes Partners Group Holding AG (PGHN:SW) (PGPHF) at Equalweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
